{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:41:42Z","timestamp":1792809702584,"version":"4.5.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1160,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1365-2133.2012.10905.x","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T17:20:44Z","timestamp":1330449644000},"page":"194-197","source":"Crossref","is-referenced-by-count":27,"title":["Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions"],"prefix":"10.1093","volume":"167","author":[{"given":"O.E.","family":"Akilov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Piekarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Geskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2007.06.015","article-title":"Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?","volume":"43","author":"Dummer","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB2|cit2","first-page":"1595","volume-title":"Williams Hematology","author":"Geskin","year":"2010"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB3|cit3","first-page":"91","volume-title":"Clinical Practice Guidelines in Oncology: Non-Hodgkin\u2019s lymphomas","volume":"1","author":"NCCN","year":"2012"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1271\/bbb.58.1579","article-title":"Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells","volume":"58","author":"Ueda","year":"1994","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1667\/RR3192","article-title":"Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors","volume":"161","author":"Zhang","year":"2004","journal-title":"Radiat Res"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2007.11.039","article-title":"A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides","volume":"71","author":"Kamstrup","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2007.11.6202","article-title":"Inhibition of histone deacetylation: a strategy for tumor radiosensitization","volume":"25","author":"Camphausen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ijc.20117","article-title":"Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells","volume":"110","author":"Zhang","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7819-7-49","article-title":"The combination effect of sodium butyrate and 5-aza-2\u2032-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines","volume":"7","author":"Cho","year":"2009","journal-title":"World J Surg Oncol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0006-2952(02)01261-3","article-title":"Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo","volume":"64","author":"Sasakawa","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2012.10905.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2307\/3579000","article-title":"Modulation of radiation-induced apoptosis and G2\/M block in murine T-lymphoma cells","volume":"141","author":"Palayoor","year":"1995","journal-title":"Radiat Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10905.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10905.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:55:14Z","timestamp":1676382914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/1\/194\/6614085"}},"subtitle":["Romidepsin and LEBT for CTCL"],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10905.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,28]]}}}